Results for tag: "Restless Legs Syndrome Drug"

Restless Legs Syndrome (RLS) is a neurological disorder characterized by an irresistible urge to move the legs. It is often accompanied by uncomfortable sensations in the legs, such as tingling, burning, or itching. Treatment for RLS typically involves medications that act on the central nervous system (CNS). These drugs are typically dopamine agonists, which act on the dopamine receptors in the brain to reduce the symptoms of RLS. Other drugs used to treat RLS include anticonvulsants, opioids, and benzodiazepines. The RLS drug market is a subset of the larger CNS drug market. It is a relatively small market, but is growing due to increased awareness of the disorder and the availability of new treatments. The market is highly competitive, with several major pharmaceutical companies offering drugs for the treatment of RLS. Some of the companies in the RLS drug market include GlaxoSmithKline, Pfizer, Merck, and Novartis. Other companies, such as Sunovion, Jazz Pharmaceuticals, and Teva Pharmaceuticals, also offer drugs for the treatment of RLS. Show Less Read more